| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/11/1995 | EP0552227B1 Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation |
| 01/11/1995 | EP0544821B1 Indole derivatives as antiallergy and antiinflammatory agents |
| 01/11/1995 | CN1027369C Excitatory amino acid antagonists |
| 01/10/1995 | US5380921 Aminophosponic acid derivative |
| 01/10/1995 | US5380866 Alkyl substituted nitroimidazole acetic acids |
| 01/10/1995 | US5380851 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation |
| 01/10/1995 | US5380837 Alpha-methyldopa or its salt with D-glucose residues attached in alpha fashion to either or both hydroxyls; pharmaceutical compositions |
| 01/10/1995 | US5380747 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 01/10/1995 | US5380742 4H-thieno[3,4-c]pyrrole derivatives |
| 01/10/1995 | US5380730 Pyridine compounds which have useful pharmaceutical utility |
| 01/10/1995 | US5380729 12-hetero substituted 6,11-ethano-6,11-dihydrobenzo (b) quinolizinium salts and compositions and method of use thereof |
| 01/10/1995 | US5380726 Interleukin inhibitors |
| 01/10/1995 | US5380724 Piperazine and homopiperazine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 01/10/1995 | US5380715 Ap4 A as a hypotensive agent |
| 01/10/1995 | US5380714 2-furyl-triazalo [1,5-a]-[1,3,5]triazines and pyrazolo [2,3-a][1,3,5]triazines |
| 01/10/1995 | US5380712 Truncated human serum albumin polypeptides as plasma expanding agents |
| 01/10/1995 | US5380710 Pharmaceutical compositions containing ACTH (1-24) for the therapy of shock conditions and respiratory and cardiocirculatory insufficiences |
| 01/05/1995 | WO1995000844A1 Novel clinical marker and therapeutic agent in kidney stone disease and methods of use |
| 01/05/1995 | WO1995000649A1 Lipoprotein associated phospholipase a2, inhibitors thereof and use of the same in diagnosis and therapy |
| 01/05/1995 | WO1995000537A1 New compound and its preparation |
| 01/05/1995 | WO1995000517A1 Process for producing imidazole derivative |
| 01/05/1995 | WO1995000514A1 Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 01/05/1995 | WO1995000512A1 Positive inotropic and lusitropic pyrroloquinolinone derivatives |
| 01/05/1995 | WO1995000505A1 Aminoacid derivatives as no synthase inhibitors |
| 01/05/1995 | WO1995000477A1 Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system |
| 01/05/1995 | WO1995000472A1 1,2 diacylated hydrazine derivatives and their use as all adhesion inhibitors |
| 01/05/1995 | WO1995000471A1 Benzene derivative useful for ischemic diseases |
| 01/05/1995 | WO1995000169A1 Medical use of stem bromelain protease |
| 01/05/1995 | WO1995000161A1 Neuropeptide y antagonists and agonists |
| 01/05/1995 | WO1995000135A1 Medical treatment using thyroid hormones |
| 01/05/1995 | CA2165822A1 The medical treatment using thyroid hormones |
| 01/05/1995 | CA2165790A1 New compound and its preparation |
| 01/05/1995 | CA2165787A1 Medical use of stem bromelain protease |
| 01/05/1995 | CA2165662A1 Benzene derivatives effective on ischemic diseases |
| 01/05/1995 | CA2165200A1 Neuropeptide y antagonists and agonists |
| 01/05/1995 | CA2161436A1 Antiproliferative naphthyridines |
| 01/04/1995 | EP0632129A1 Recombinant foamy virus vectors for medicinal and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 01/04/1995 | EP0632053A2 Cyclic adhesion inhibitors |
| 01/04/1995 | EP0632036A2 Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses |
| 01/04/1995 | EP0632033A1 Novel benzopyran derivative |
| 01/04/1995 | EP0632020A1 Allophanic acid derivatives |
| 01/04/1995 | EP0632016A1 1,2-Diacylated hydrazine derivatives and their use as cell adhesion inhibitors |
| 01/04/1995 | EP0631786A1 Lys - plasminogen in the prevention and treatment of ischemia and reperfusian injury |
| 01/04/1995 | EP0631776A1 Use of beta-naphthoquinone for accelerating the proliferation of endothelial cells and inhibiting no synthases |
| 01/04/1995 | EP0631727A1 Lipase inhibitor derived from a defatted rice germ |
| 01/04/1995 | CN1097006A O-aryl ethers of morphinans |
| 01/04/1995 | CN1027271C Method for preparation of polypeptide with nor-state and nor-cyclostatine |
| 01/04/1995 | CN1027262C Preparing of benzazepine and benzothiazepine derivatives |
| 01/03/1995 | US5378732 Method of reducing the rate of reocclusion of arteries |
| 01/03/1995 | US5378718 Cardiovascular activity, hypotensive |
| 01/03/1995 | US5378716 Pyrazol-1-yl phenoxyacetic acid compounds which have useful pharmaceutical utility |
| 01/03/1995 | US5378713 Substituted thienopyrans as antihypertensive agents |
| 01/03/1995 | US5378709 Administering 1-(2-naphthylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine or a pharmaceutically acceptable salt thereof to mammals |
| 01/03/1995 | US5378702 Thiadizinones |
| 01/03/1995 | US5378699 Treatment of immune diseases, cell proliferation, restenosis and smooth muscle cells |
| 01/03/1995 | US5378698 Benzothiazepine derivatives |
| 01/03/1995 | US5378694 Acyl and alkoxy substituted quinolines |
| 01/03/1995 | US5378692 Method of lowering lipids |
| 01/03/1995 | US5378464 Modulation of inflammatory responses by administration of GMP-140 or antibody to GMP-140 |
| 01/03/1995 | CA1333803C .alpha.-substituted 4-(quinolin-2-yl-methoxy)phenylacetic acids and esters |
| 01/03/1995 | CA1333802C Substituted 4-(quinolin-2-yl-methoxy)phenyl-acetic acid derivatives |
| 12/31/1994 | CA2126994A1 Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses |
| 12/29/1994 | CA2126038A1 Allophanic acid derivatives |
| 12/28/1994 | EP0630896A1 Substituted mono- and bipyridylmethyl derivatives as angiotensin II antagonist |
| 12/28/1994 | EP0630895A1 4-Bicyclic substituted dihydropyridines, process for their preparation and their use in medicaments |
| 12/28/1994 | EP0630649A1 Combination of an inhibitor of inducible nitric oxide synthase (iNOS) and an antiinflammatory agent, e.g. a corticosteroid |
| 12/28/1994 | EP0630379A1 Cyclic ketal derivatives |
| 12/28/1994 | EP0630378A1 Cyclic ketal derivatives |
| 12/28/1994 | EP0630376A1 Condensed indole derivatives as 5ht 4?-receptor antagonists |
| 12/28/1994 | EP0630372A1 Heteroalkoxy benzazepines |
| 12/28/1994 | EP0630275A1 Fibrin sealant delivery method |
| 12/28/1994 | EP0630245A1 Protein kinase c inhibitor |
| 12/28/1994 | EP0555351B1 Oxysulfonyl carbamates |
| 12/28/1994 | CN1096783A Salt of derivative of 4-pyrimidone and preparation and medical application of same |
| 12/27/1994 | US5376748 Antiepileptic agents, anticonvulsants |
| 12/27/1994 | US5376681 Aminocoumaran derivatives, their production and use |
| 12/27/1994 | US5376673 Vasodilation |
| 12/27/1994 | US5376667 Derivatives of benzoylecgonine, ecgonine and their multiple pharmacological properties |
| 12/27/1994 | US5376661 Psychological disorders |
| 12/27/1994 | US5376638 Methods for treating renin-related disorders with amylin antagonists |
| 12/27/1994 | US5376637 Pharmaceutical preparation containing vasoactive intestinal polypeptide or its analogue |
| 12/27/1994 | US5376553 Analyzing biological fluid samples for presence of dicitrate cyclic diester which indicates no pathological calcification or predisposition towards it |
| 12/27/1994 | US5376384 Delayed, sustained-release pharmaceutical preparation |
| 12/27/1994 | CA2126719A1 Piperidines and piperazines |
| 12/27/1994 | CA1333714C Quinoline ether alkanoic acids for use as inhibitors of leukotriene biosynthesis |
| 12/25/1994 | CA2126397A1 4-bicyclically substituted dihydropyridines, processes for their preparation and their use in medicaments |
| 12/22/1994 | WO1994029720A1 Leukocyte adhesion assay |
| 12/22/1994 | WO1994029309A1 Spiro-substituted azacycles as neurokinin antagonists |
| 12/22/1994 | WO1994029305A1 N-[[1-[4-(4-fluorophenoxy)butyl]-4-piperidinyl]-n-methylamino]-2-benzothiazolols as class iii antiarrhythmic agents |
| 12/22/1994 | WO1994029299A1 Imidazole lipoxygenase inhibitors |
| 12/22/1994 | WO1994029298A1 8-amino-7-chloro-1,4-benzodioxan-5-carboxylic acid, -1-butyl-4-piperidinyl ester as a 5-ht4-receptor antagonist |
| 12/22/1994 | WO1994029289A1 Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia |
| 12/22/1994 | WO1994029280A1 Pyrimidine cyanoguanidines as k-channel blockers |
| 12/22/1994 | WO1994029262A1 Lipoxin compounds |
| 12/22/1994 | WO1994028899A1 New use of ambasilide |
| 12/22/1994 | WO1994028896A1 Imidazole 5-position substituted angiotensin ii antagonists |
| 12/22/1994 | WO1994028895A2 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| 12/22/1994 | WO1994028886A1 Use of natural products and related synthetic compounds for the treatment of cardiovascular disease |
| 12/22/1994 | WO1994028880A1 Extended release, film-coated tablet of astemizole and pseudoephedrine |
| 12/22/1994 | WO1994028721A1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity |